J Zhou1, Y Wu, L Wang, L Rauova, V M Hayes, M Poncz, D W Essex. 1. The Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Jiangsu Institute of Hematology, Soochow University, Suzhou, China.
Abstract
BACKGROUND: ERp57 is required for platelet function; however, whether ERp57 contributes to fibrin generation is unknown. METHODS AND RESULTS: Using an inhibitory anti-ERp57 antibody (mAb1), Pf4-Cre/ERp57(fl/fl) mice, Tie2-Cre/ERp57(fl/fl) mice, and mutants of ERp57, we analyzed the function of ERp57 in laser-induced thrombosis. Fibrin deposition was decreased in Pf4-Cre/ERp57(fl/fl) mice, consistent with a role for platelet ERp57 in fibrin generation. Fibrin deposition was further decreased with infusion of mAb1 and in Tie2-Cre/ERp57(fl/fl) mice, consistent with endothelial cells also contributing to fibrin deposition. Infusion of eptibifatide inhibited platelet and fibrin deposition, confirming a role for platelets in fibrin deposition. Infusion of recombinant ERp57 corrected the defect in fibrin deposition but not platelet accumulation, suggesting a direct effect of ERp57 on coagulation. mAb1 inhibited thrombin generation in vitro, consistent with a requirement for ERp57 in coagulation. Platelet accumulation was decreased to similar extents in Pf4-Cre/ERp57(fl/fl) mice, Tie2-Cre/ERp57(fl/fl) mice and normal mice infused with mAb1. Infusion of completely inactivated ERp57 or ERp57 with a non-functional second active site inhibited fibrin deposition and platelet accumulation, indicating that the isomerase activity of the second active site is required for these processes. CONCLUSION: ERp57 regulates thrombosis via multiple targets.
BACKGROUND:ERp57 is required for platelet function; however, whether ERp57 contributes to fibrin generation is unknown. METHODS AND RESULTS: Using an inhibitory anti-ERp57 antibody (mAb1), Pf4-Cre/ERp57(fl/fl) mice, Tie2-Cre/ERp57(fl/fl) mice, and mutants of ERp57, we analyzed the function of ERp57 in laser-induced thrombosis. Fibrin deposition was decreased in Pf4-Cre/ERp57(fl/fl) mice, consistent with a role for platelet ERp57 in fibrin generation. Fibrin deposition was further decreased with infusion of mAb1 and in Tie2-Cre/ERp57(fl/fl) mice, consistent with endothelial cells also contributing to fibrin deposition. Infusion of eptibifatide inhibited platelet and fibrin deposition, confirming a role for platelets in fibrin deposition. Infusion of recombinant ERp57 corrected the defect in fibrin deposition but not platelet accumulation, suggesting a direct effect of ERp57 on coagulation. mAb1 inhibited thrombin generation in vitro, consistent with a requirement for ERp57 in coagulation. Platelet accumulation was decreased to similar extents in Pf4-Cre/ERp57(fl/fl) mice, Tie2-Cre/ERp57(fl/fl) mice and normal mice infused with mAb1. Infusion of completely inactivated ERp57 or ERp57 with a non-functional second active site inhibited fibrin deposition and platelet accumulation, indicating that the isomerase activity of the second active site is required for these processes. CONCLUSION:ERp57 regulates thrombosis via multiple targets.
Authors: Lisa-Marie Holbrook; Nicholas A Watkins; Alan D Simmonds; Chris I Jones; Willem H Ouwehand; Jonathan M Gibbins Journal: Br J Haematol Date: 2009-12-08 Impact factor: 6.998
Authors: Teshell K Greene; Cheng Wang; Jessica D Hirsch; Li Zhai; Jamie Gewirtz; Michael A Thornton; Hongzhi Z Miao; Steven W Pipe; Randal J Kaufman; Rodney M Camire; Valder R Arruda; M Anna Kowalska; Mortimer Poncz Journal: Blood Date: 2010-09-17 Impact factor: 22.113
Authors: Christian Schulz; Nina V Leuschen; Thomas Fröhlich; Michael Lorenz; Susanne Pfeiler; Christian A Gleissner; Elisabeth Kremmer; Mirjam Kessler; Alexander G Khandoga; Bernd Engelmann; Klaus Ley; Steffen Massberg; Georg J Arnold Journal: Blood Date: 2010-01-27 Impact factor: 22.113
Authors: Sol Schulman; Pavan Bendapudi; Anish Sharda; Vivien Chen; Lola Bellido-Martin; Reema Jasuja; Barbara C Furie; Robert Flaumenhaft; Bruce Furie Journal: Antioxid Redox Signal Date: 2015-11-18 Impact factor: 8.401
Authors: Junsong Zhou; Yi Wu; Lubica Rauova; Gavin Koma; Lu Wang; Mortimer Poncz; Hong Li; Tong Liu; Karen P Fong; Joel S Bennett; Satya P Kunapuli; David W Essex Journal: Blood Date: 2022-03-31 Impact factor: 22.113
Authors: Junsong Zhou; Yi Wu; Lu Wang; Lubica Rauova; Vincent M Hayes; Mortimer Poncz; David W Essex Journal: J Clin Invest Date: 2015-11-03 Impact factor: 14.808
Authors: Junsong Zhou; Yi Wu; Fengwu Chen; Lu Wang; Lubica Rauova; Vincent M Hayes; Mortimer Poncz; Hong Li; Tong Liu; Junling Liu; David W Essex Journal: Blood Date: 2017-06-02 Impact factor: 22.113